Osteopontin (OPN) is an inflammatory cytokine highly expressed in multiple sclerosis (MS) plaques. In a previous work, we showed that four OPN polymorphisms form three haplotypes (A, B, and C) and that homozygotes for haplotype-A display lower OPN levels than non-AA subjects. In this work, we evaluated the distribution of these OPN haplotypes in 425 MS patients and 688 controls. Haplotype-A homozygotes had about 1.5 lower risk of developing MS than non-AA subjects. Clinical analysis of 288 patients showed that AA patients displayed slower switching from a relapsing remitting to a secondary progressive form and milder disease with slower evolution of disability. MS patients displayed increased OPN serum levels, which were partly due to the increased frequency of non-AA subjects. Moreover in AA patients, OPN levels were higher than in AA controls and similar to those found in both non-AA patients and controls, which suggests a role of the activated immune response. These data suggest that OPN genotypes may influence MS development and progression due to their influence on OPN levels. (C) 2005 Elsevier B.V. All rights reserved.
|Titolo:||Osteopontin gene haplotypes correlate with multiple sclerosis development and progression|
|Data di pubblicazione:||2005|
|Citazione:||Osteopontin gene haplotypes correlate with multiple sclerosis development and progression / Chiocchetti A; Comi C; Indelicato M; Castelli L; Mesturini R; Bensi T; Mazzarino M.C.; Giordano M; D'Alfonso S; Momigliano-Richiardi P; Liguori M; Zorzon M; Amoroso A; Trojano M; Monaco F; Leone M; Magnani C; Dianzani U. - In: JOURNAL OF NEUROIMMUNOLOGY. - ISSN 0165-5728. - 163:1-2(2005), pp. 172-178.|
|Appare nelle tipologie:||1.1 Articolo in rivista|